Rule 8.3 - Tepnel Life Sciences
July 21 2005 - 11:57AM
UK Regulatory
FORM 8.3
DEALINGS BY PERSONS WHO OWN OR CONTROL 1% OR MORE OF ANY CLASS OF RELEVANT
SECURITY
(Rule 8.3 of The City Code on Takeovers and Mergers)
Name of purchaser/vendor * Framlington Investment Management
Company dealt in Tepnel Life Sciences
Relevant security dealt in Ordinary 1p
If a connected EFM, name of
offeree/offeror with which
connected
If a connected EFM, nature of
connection #
Date of dealing 18th July 2005
DEALINGS *
Amount bought Price per unit (currency must be stated)
Amount sold Price per unit (currency must be stated)
250,000 �0.10p
Resultant total amount and 15,594,348 (7.32%)
percentage of the same relevant
security owned or controlled
IS A SUPPLEMENTAL FORM 8 (DERIVATIVE)/FORM 8 (OPTION) ATTACHED? / NO
Date of disclosure 21st July 2005
Contact name Bill Kennedy
Telephone number 0207-330-6516
* Specify the owner or controller in addition to the person dealing. The naming
of nominees or vehicle companies is insufficient. In the case of disclosure of
dealings by fund managers on behalf of discretionary clients, the clients need
not be named.
# See the definition of "connected fund managers and principal traders" in the
Definitions Section of the Code.
* If disclosing dealings/holdings in derivatives or options, please attach
Supplemental Form 8 (Derivative) or Supplemental Form 8 (Option), as
appropriate.
For details of the Code's dealing disclosure requirements, see Rule 8 and its
Notes which can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk.
END
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024